STE Stock Recent News
STE LATEST HEADLINES
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
STERIS remains a high-quality, defensive cash recycler with diversified growth, expanding margins, strong cash conversion, and disciplined capital deployment. Q1 FY'26 results showed broad-based 9% revenue growth, margin expansion across all segments, and raised full-year guidance, supporting my positive investment view. Valuation is fair with upside to $270–$300/share; the company excels at recycling cash into earnings, dividends, and buybacks, despite modest top-line growth.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
STERIS plc (NYSE:STE ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Daniel A. Carestio - President, CEO & Director Julie Winter - Vice President of Investor Relations & Corporate Communications Michael J.
STERIS posts 15% EPS growth and raises FY26 revenue outlook, with all segments showing solid year-over-year gains.
Steris (STE) came out with quarterly earnings of $2.34 per share, beating the Zacks Consensus Estimate of $2.32 per share. This compares to earnings of $2.03 per share a year ago.
Long-time CFO Michael J. Tokich to be succeeded by Karen L.
DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 first quarter ended June 30, 2025. Total revenue from continuing operations for the first quarter of fiscal 2026 increased 9% to $1.4 billion compared with $1.3 billion in the first quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the first quarter was 8%.